Israel Active

Technion UK’s webinar on 31st May features Israel’s Rafi Nave, senior researcher at Israel’s Technion. He headed the development of the PillCam, the world’s first ingestible camera for imaging the digestive tract. NHS UK is about to use PillCam for 11,000 patients across England.

Israel’s PatenSee has developed an image system to detect deterioration of fistulas – the artery / vein connection from dialysis machines to patients. Over time these connections fail due to blockages (stenoses), risking blood clots and thromboses. The system is in trials at two Israeli hospitals.

Israel’s CytoReason (see previously) is partnering Swiss multinational Ferring to find new treatments for patients with inflammatory bowel disease (IBD). CytoReason’s AI technology will enable the joint building of models of diseased cells on which therapies will be tested.

Researchers from The Hebrew University of Jerusalem and Penn State College of Medicine have made an important discovery about the protein alpha-synuclein, associated with the development of Parkinson’s and dementia. It gives hope for new therapeutics to delay or halt their progression.

Israel’s Ibex Medical Analytics (see previously) has received Europe’s CE Mark for its Galen Breast image analysis solution to help pathologists detect various types of cancer. It follows successful trials in Israel and France.

Israeli founded Laguna Health aims to reduce costly hospital readmissions and shorten recovery times. Its app can provide patients in the US either with a fully digital and personalized recovery journey or enable interactions with live expert recovery coaches via text, telephone or video.

Children from Gaza, being treated free of charge by doctors at Israel’s Save a Child’s Heart (SACH), normally go home after surgery. But due to Hamas rockets, 3 post-surgery Gazan kids had to stay in the SACH children’s house and six more in the hospital itself.

Israeli volunteer medical equipment organization Yad Sarah (see previously) has sent hundreds of home hospital equipment, wheelchairs, crutches, respiratory aids etc. to reinforce its branches in the south of the country.

Two real-life stories highlight the lengths that United Hatzalah volunteers will go to treat Israeli citizens of any religion, whose lives are in danger.

The first US patients have been treated with the Tigertriever from Israel’s Rapid Medical. The device helps neurosurgeons to remove blood clots and restore blood flow to the brain following an ischemic (stroke) event. It was approved by the US FDA in March.